Receptors for human alpha interferon: are gangliosides involved?
Receptors for human alpha interferon: are gangliosides involved?
复制标题
人α干扰素受体:神经节苷脂参与其中吗?
DOI:
10.1089/jir.1984.4.305
复制
发表时间:
1984
期刊:
影响因子:
--
通讯作者:
Sarkar,FH
中科院分区:
文献类型:
--
作者:
Gupta,SL;Raziuddin,A;Sarkar,FH
Interferon (IFN) action on cells must begin with an interaction with cellular receptors. Binding and cross-linking experiments reported earlier with purified125T-labeled recombinant human (Hu) IFN-α2have revealed that IFN-α2binds to a specific macromolecular receptor on human cells (Joshi et al., J. Biol. Chem. 257, 13884–13887, 1982). Based on indirect evidence such as neutralization of the antiviral action of IFN preparations by gangliosides and binding of IFNs to gangliosides coupled to solid supports, it has been suggested by various investigators that gangliosides may be a part of the IFN-α/β receptors. Experiments presented here indicate that gangliosides could block the antiviral activity of HuIFN-β, but not of HuIFN-α, although both species of IFN bound strongly to gangliosides coupled to poly-L-lysine-agarose. Furthermore, gangliosides did not inhibit the binding of125I-labeled HuIFN-α2to specific receptors on human cells, and this binding was competed out by unlabeled HuIFN-α2and HuIFN-α(Le) which were preincubated with gangliosides. However, the capacity of HuIFN-β to compete for the receptors was abolished by preincubation with gangliosides. These results were confirmed by cross-linking experiments to identify the IFN-receptor complex by gel electrophoresis. The results indicate that at least in the case of HuIFN-α species, the ganglioside binding is apparently not at the active site of the IFN molecules required for interaction with the receptors on the cell surface.